Copeland NG, Jenkins NA, Court DL. Recombineering: A Powerful New Tool for Mouse Functional Genomics. Nature Genetics. 2001 2: 769-779.

Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000 28(1): 41-51.

Hatten ME, Heintz N. Large-scale genomic approaches to brain development and circuitry. Annu Rev Neurosci. 2005 28:89-108.

Heintz N. Analysis of mammalian central nervous system gene expression and function using bacterial artificial chromosome-mediated transgenesis. Human Molecular Genetics. 2000 9(6): 937-943.

Kucharczuk KL, Love CM, Dougherty NM, Goldhamer DJ. Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages. Development. 1999 126(9): 1957-65.

Liu P, Jenkins N, Copeland NG. A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations. Genome Research. 2003 13:476-484.

Misgeld T, Burgess RW, Lewis RM, Cunningham JM, Lichtman JW, Sanes JR. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron. 2004 36(4): 635-48.

Sasazuki T, Sawada T, Sakon S, Kitamura T, Kishi T, Okazaki T, Katano M, Tanaka M, Watanabe M, Yagita H, Okumura K, Nakano H. Identification of a novel transcriptional activator, BSAC, by a functional cloning to inhibit tumor necrosis factor-induced cell death. J Biol Chem. 2002 277(32): 28853-60.

van der Neut R. Targeted gene disruption: applications in neurobiology.J Neurosci Methods. 1997 71(1):19-27.

Yoon K, Gaiano N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci. 2005 8(6):709-15.